NCT01915953View on ClinicalTrials.gov

A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Anemia
Trial Locations (1)

70300

Assaf Harofeh Medical Center, Beer Yaacov

Sponsors

Lead Sponsor

OrSense, Ltd.
All Listed Sponsors
lead

OrSense, Ltd.

INDUSTRY

NCT01915953 - A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP | Biotech Hunter | Biotech Hunter